GRAND RAPIDS, Mich. (WOOD) — Many people manage their asthma with an inhaler — but they may not be using it correctly. Studies show that nearly 90% of patients with an inhaler make at least one ...

To reach the lungs, medicine from an inhaler must navigate the narrow passage of the throat, as seen in his aluminum model, without sticking to the moist sides of the passage. Tens of millions of ...

Nearly six-and-a-half million children in the United States suffer from asthma. Most use an inhaler to help keep their airways open. But experts say most children make mistakes when using an inhaler.

NEW YORK (CBSNewYork) -- Six and a half million children in the United States suffer from asthma and use inhalers to keep their airways open, but most kids aren't using them correctly, dramatically ...

Inhalers may be prescribed to people who have a variety of health conditions both chronic and acute, including asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. If you're new to ...

(BPT) - Fifteen million people in the United States have been told by a healthcare provider that they have chronic obstructive pulmonary disease, or COPD, and more than 50 percent of these patients ...

In the first study to evaluate inhaler technique in children hospitalized for asthma - the group at highest risk for complications and death from asthma - researchers found that nearly half of ...

(Reuters Health) – Less than one in five people who need to use asthma inhalers or epinephrine auto-injectors know how to use them properly, a small U.S. study suggests People with severe allergies or ...

person holding blue asthma inhaler Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Food and Drug Administration said Tuesday it is taking a ...

Researchers with two pharmaceutical companies are nearing the final stages of developing an inhaler they said offers an antibody-based treatment to COVID-19. Augmenta Bioworks and TFF Pharmaceuticals' ...